Response Genetics, Inc (RGDXQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
+0.0000 (100.00%)
At close: Jan 5, 2026

Response Genetics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2014FY 2013FY 2012FY 2011FY 2010
Period Ending
Jan '26 Dec '14 Dec '13 Dec '12 Dec '11 Dec '10
01245463046
Market Cap Growth
-99.93%-72.66%-1.49%52.51%-34.34%136.20%
Enterprise Value
-1642362840
Last Close Price
0.000.321.161.391.532.48
PS Ratio
-0.732.272.431.322.14
PB Ratio
0.00-10.497.80-84.08-4.87-13.90
P/TBV Ratio
--9.00---
EV/Sales Ratio
-0.962.101.921.221.88
Debt / Equity Ratio
-2.22-8.260.23-2.29-0.23-
Net Debt / Equity Ratio
-1.86-6.36-1.1914.380.051.26
Net Debt / EBITDA Ratio
-0.72-0.590.941.090.061.02
Net Debt / FCF Ratio
-0.70-0.520.960.920.060.60
Asset Turnover
1.321.061.141.532.451.99
Quick Ratio
1.601.992.542.730.981.50
Current Ratio
1.802.222.712.841.141.65
Return on Equity (ROE)
--597.07%-307.49%---
Return on Assets (ROA)
-67.88%-53.52%-28.67%-39.16%-37.43%-26.35%
Return on Invested Capital (ROIC)
-258.85%-520.79%----
Return on Capital Employed (ROCE)
-231.30%-160.60%-64.10%-67.70%-282.20%-96.40%
Earnings Yield
-18222183.33%-111.57%-17.86%-17.02%-19.08%-10.26%
FCF Yield
-16804708.97%-116.87%-15.85%-18.51%-18.09%-15.12%
Buyback Yield / Dilution
-10.91%-15.75%-25.20%-39.83%-7.49%-34.01%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.